Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response

syn51301409

Created By NF Service nf-osi-service

program: NF-OSI
dataType:
grantDOI: https://doi.org/10.54464/pc.gr.160969
keywords:
studyName: Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response
dataStatus: Under Embargo
initiative: Biology and Therapeutic Development for Cutaneous Neurofibromas
studyLeads: Alice Soragni Sara Gosline
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1785456000000
institutions: University of Colorado Anschutz Pacific Northwest National Laboratory
fundingAgency: NTAP
manifestation:
embargoEndDate: 1801353600000
grantStartDate: 1682899200000
relatedStudies: syn51116567 syn11374354 syn4939892 syn4939910
studyFileviewId: syn51301431
alternateDataRepository:
syn51301410
syn53164954
syn51301411
syn66351483
syn51301431
syn66255882
syn70366294
syn51301412
syn70283190
syn70766463
syn73875481
syn73875571
syn73875643
syn73875462
syn73875559
syn73875629
syn73875548
syn73875617
syn73875698
syn73875532
syn73875609
syn73875683
syn73875518
syn73875594
syn73875672
syn73875502
syn73875582
syn73875657
syn65473029
syn65903810

Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response page is loading…